SVB Leerink analyst Andrew Berens reiterates Incyte (NASDAQ:INCY) with a Underperform and maintains $63 price target.
Santa Comes To Wall Street? US Stocks Poised To Open Higher In 2022’s Final Trading Week
The index futures point to a moderately higher opening on Tuesday, as traders return to their desks after an extended holiday weekend in observance of Christmas. In the absence of any major trading cues, a couple of house price readings could guide sentiment. Trading volume could be light, lending less credibility to any potential move.
